Correlation Between Corvus Pharmaceuticals and CEL SCI
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and CEL SCI Corp, you can compare the effects of market volatilities on Corvus Pharmaceuticals and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and CEL SCI.
Diversification Opportunities for Corvus Pharmaceuticals and CEL SCI
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Corvus and CEL is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and CEL SCI go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and CEL SCI
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to under-perform the CEL SCI. But the stock apears to be less risky and, when comparing its historical volatility, Corvus Pharmaceuticals is 2.45 times less risky than CEL SCI. The stock trades about -0.39 of its potential returns per unit of risk. The CEL SCI Corp is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 45.00 in CEL SCI Corp on November 28, 2024 and sell it today you would lose (9.00) from holding CEL SCI Corp or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. CEL SCI Corp
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| CEL SCI Corp |
Corvus Pharmaceuticals and CEL SCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and CEL SCI
The main advantage of trading using opposite Corvus Pharmaceuticals and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| CEL SCI vs. Beam Therapeutics | CEL SCI vs. Editas Medicine | CEL SCI vs. Caribou Biosciences | CEL SCI vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |